Larimar Therapeutics
dose dependent increases in levels observed in platelets with daily dosing i | Larimar Therapeutics
Company
Deck Type
Sector
Industry
Deck date
October 2022
Slide
22 of 32
Similar slides by Larimar Therapeutics
See diffirences between slides (animation)
Investor Presentation
November 2023
increases in levels observed in buccal cells cohort | Larimar Therapeutics
Investor Presentation
November 2023
increases in levels observed in skin cells cohort | Larimar Therapeutics
Investor Presentation
November 2023
dose dependent increases in levels observed in skin and buccal cells in phase | Larimar Therapeutics
Investor Presentation
November 2023
increases in levels in phase trial cohort | Larimar Therapeutics
Related slides by other companies
Hugo Boss
Results
May 2022
strong growth trajectory in the continues sales increases levels momentum in the market continues due to strong progress in fostering brand image with particular strength as reflected by high double digit sales growth | Hugo Boss
DICE Therapeutics
Investor Presentation
March 2023
week levels and week pasi scores nice | DICE Therapeutics
DICE Therapeutics
Investor Presentation
March 2023
demonstrated a dose dependent increase in serum a to levels comparable to | DICE Therapeutics
Other recent decks by Larimar Therapeutics
See all presentations (3 decks)
Investor Presentation
November 2023
Results
November 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights